Difference in decline in renal function due to cisplatin after a short or long hydration scheme in non–small‐cell lung cancer: A retrospective cohort study (HYCIS‐XL)-Reference-Cited by-同舟云学术

Difference in decline in renal function due to cisplatin after a short or long hydration scheme in non–small‐cell lung cancer: A retrospective cohort study (HYCIS‐XL)

Published:2020-06-13 Issue:5 Volume:45 Page:1153-1158
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Niggebrugge‐Mentink Kelly L.¹^ORCID,Beex‐Oosterhuis Marieke M.¹,Horst Peter G. J.²,Poll Matthijs E. C.³,Dieleman Hetty G.¹,Kesteren Charlotte¹

Affiliation:

1. Hospital Pharmacist Albert Schweitzer hospital (Hospital Pharmacy) Dordrecht The Netherlands

2. Hospital Pharmacist Isala (Hospital Pharmacy) Zwolle The Netherlands

3. Hospital Pharmacist Máxima MC (Hospital Pharmacy) Veldhoven The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13200

Reference22 articles.

1. Dutch Medicines Evaluation Board (CBG‐MEB).Summary of product characteristics cisplatin. 20‐06‐2013.https://www.geneesmiddeleninformatiebank.nl/ords/f?p=111:3:0:SEARCH:NO::P0_DOMAIN P0_LANG P3_RVG1:H NL 15603. Accessed September 5 2018

2. Cisplatin Nephrotoxicity: A Review

3. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care

4. Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review

5. Retrospectief, observationeel, oriënterend onderzoek naar nefrotoxiciteit bij behandeling met cisplatine volgens twee verschillende hydratieschema’s;Ambachtsheer‐Peijs CEM;Wet Platf PW,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydration Methods for Cisplatin Containing Chemotherapy: A Systematic Review;The Oncologist;2023-11-23

2. Protective effect of food derived nutrients on cisplatin nephrotoxicity and its mechanism;Food & Function;2022

3. Hyponatremia timing, incidence, and associated risk factors in patients treated with cisplatin for lung cancer: a retrospective study;Journal of Population Therapeutics and Clinical Pharmacology;2022-01-01

4. The why and how of maintaining hydration during cancer therapy;Current Opinion in Supportive & Palliative Care;2020-09-29